Mingus
Well-known member
Real-Time Tracking of Control Measures for Emerging Infections <hr style="color: rgb(209, 209, 225);" size="1"> <!-- / icon and title --> <!-- message --> http://aje.oxfordjournals.org/cgi/co...full/160/6/517
ORIGINAL CONTRIBUTIONS
Invited Commentary: Real-Time Tracking of Control Measures for Emerging Infections
<nobr>Marc Lipsitch<sup>1</sup><sup> </sup></nobr> and <nobr>Ca
rl T. Bergstrom<sup>2</sup></nobr> [SIZE=-1] <sup>1</sup> Department of Epidemiology, Harvard School of Public Health, Boston, MA.
<sup>2</sup> Department of Biology, University of Washington, Seattle, WA. [/SIZE]
[SIZE=-1]Received for publication May 17, 2004; accepted for publication June 3, 2004.[/SIZE]
<!-- null --> Health officials faced a daunting task with the emergence of<sup> </sup>severe acute respiratory syndrome (SARS) last year: forecasting<sup> </sup>the trajectory of an emerging infectious disease and implementing<sup> </sup>effective control measures, even as the etiologic agent was<sup> </sup>still being identified. Investigators initially had little to<sup> </sup>go on beyond crude epidemiologic data such as the timing of<sup> </sup>new cases (the epidemic curve). With such limited data, it was<sup> </sup>difficult to disentangle two fundamental epidemiologic quantities:<sup> </sup>the time from one transmission of the infection to the next,<sup> </sup>known as the serial interval or generation time, and the average<sup> </sup>number of secondary cases resulting from each infection, known<sup> </sup>as the reproductive number.<sup> </sup>
A simple example illustrates the problem. Compare two idealized<sup> </sup>diseases, A and B. Disease A has a short generation time of<sup> </sup>4 days but has relatively low transmissibility, such that each<sup> </sup>primary infection generates two secondary infections. Disease<sup> </sup>B has a longer generation time of 8 days but is more transmissible,<sup> </sup>such that each primary infection generates four secondary infections.<sup> </sup>The initial epidemic curves for these two infections will be<sup> </sup>nearly superimposable, with approximately a doubling of new<sup> </sup>cases every 4 days. (These calculations are approximate. In<sup> </sup>fact, the generation time for any given transmission will be<sup> </sup>a random variable, with some distribution. This distribution<sup> </sup>will affect the precise doubling time of the epidemic and will<sup> </sup>also affect the shape of the epidemic curve in the period before<sup> </sup>the epidemic enters an exponential growth phase (1?3).)<sup> </sup>Thus, investigators cannot separate generation time from reproductive<sup> </sup>number on the basis of the epidemic curves alone. As a result,<sup> </sup>they are limited in their ability to predict the efficacy of<sup> </sup>potential interventions. Despite nearly identical epidemic curves,<sup> </sup>an outbreak of disease A can stemmed by an intervention that<sup> </sup>reduces transmission threefold, while disease B will continue<sup> </sup>to spread even with such control measures in place.<sup> </sup>
In the current issue of the Journal, Wallinga and Teunis (4)<sup> </sup>present a statistical escape from this analytical Catch-22.<sup> </sup>Their approach is this: Once epidemiologists have traced the<sup> </sup>chains of transmission in a single isolated outbreak, they can<sup> </sup>use the transmission network to infer the distribution of generation<sup> </sup>times for that disease. This distribution, which results from<sup> </sup>the biology of host-pathogen interaction, should be relatively<sup> </sup>constant in comparison with transmission rates, which will vary<sup> </sup>from location to location and over the course of an epidemic<sup> </sup>as the pool of susceptible persons declines and as control measures<sup> </sup>are implemented. Therefore, investigators can use this generation<sup> </sup>time distribution as a grounding point from which to infer the<sup> </sup>reproductive number, R, from epidemic curves observed in other<sup> </sup>settings where extensive contact tracing may not have been achieved.<sup> </sup>Most importantly, Wallinga and Teunis describe an elegant method<sup> </sup>for following the instantaneous reproductive number as it evolves<sup> </sup>over time in a single epidemic. They provide a means of transforming<sup> </sup>the time series of cases, along with a "known" distribution<sup> </sup>for the generation time, into a time series of estimated values<sup> </sup>for the instantaneous reproductive number on each day.<sup> </sup>
This method allows nearly real-time tracking of the effect<sup> </sup>of control measures and other changes in an epidemic on the<sup> </sup>level of transmission ongoing in the population. Estimates are<sup> </sup>not precisely real-time, because accurate estimates of the instantaneous<sup> </sup>reproductive number on a given date cannot be made until some<sup> </sup>time after that date. Specifically, one can only estimate the<sup> </sup>number of persons a given case has infected when a sufficient<sup> </sup>amount of time has passed that all patients with secondary cases<sup> </sup>generated by that case (and by other, surrounding cases) have<sup> </sup>become infected, become symptomatic, and had their infections<sup> </sup>reported. While this lag period (slightly more than the generation<sup> </sup>time, plus the incubation period, plus the reporting delay)<sup> </sup>could be decades long for diseases with extended latency periods<sup> </sup>such as human immunodeficiency virus disease, in the case of<sup> </sup>SARS the lag period is a matter of a few weeks, and the information<sup> </sup>provided is as fresh as one could obtain, given the available<sup> </sup>data.<sup> </sup>
Wallinga and Teunis?s elegantly simple approach is related<sup> </sup>to more complex applications of back-calculation that have been<sup> </sup>used to derive incidence of infection from data on disease prevalence<sup> </sup>or incidence in human immunodeficiency virus disease (5) and<sup> </sup>to derive annual average reproductive numbers from case data<sup> </sup>in the United Kingdom epidemic of bovine spongiform encephalopathy<sup> </sup>(6). The present work is distinguished by its real-time applicability<sup> </sup>to a rapidly transmitted disease and its requirements for only<sup> </sup>the serial interval distribution and the epidemic curve as inputs.<sup> </sup>
In their report (4), Wallinga and Teunis demonstrate the power<sup> </sup>of this analytical approach by improving our understanding of<sup> </sup>the 2003 SARS outbreaks in Hong Kong, Vietnam, Singapore, and<sup> </sup>Canada. The authors find that despite the very different epidemic<sup> </sup>curves observed in each location, pre-intervention reproductive<sup> </sup>numbers appear to have been similar. Furthermore, they infer<sup> </sup>that control interventions appear to have reduced transmission<sup> </sup>rates approximately fourfold in each location?enough to<sup> </sup>stop the epidemics, but only barely.<sup> </sup>
Like any model, this one has some limitations, which the authors<sup> </sup>note. First, the method makes the simplifying assumption of<sup> </sup>independence of transmission events?that the assignment<sup> </sup>of a source to any case A is independent of the assignment of<sup> </sup>the source to each other case B. This is, at best, an approximation.<sup> </sup>For example, if different persons vary in their degree of infectiousness<sup> </sup>(e.g., because of differences in viral shedding) or in their<sup> </sup>duration of infectiousness, the numbers of secondary infections<sup> </sup>per individual will be overdispersed (even within the same short<sup> </sup>time period). Put another way, if we know that case i was still<sup> </sup>infectious at a time when case j became infected, we know that<sup> </sup>case i is a likely candidate for having infected other secondary<sup> </sup>cases around the same time. Second, the method assumes that<sup> </sup>interventions do not affect the generation time of the pathogen.<sup> </sup>In reality, when interventions involve improved monitoring followed<sup> </sup>by either isolation or effective treatment, most transmissions<sup> </sup>will occur early, before detection. As a result, the mean generation<sup> </sup>time will be reduced, and the algorithm presented here could<sup> </sup>lead to an overestimate of the instantaneous transmission rate<sup> </sup>for the period subsequent to intervention.<sup> </sup>
So will Wallinga and Teunis?s approach work despite these<sup> </sup>limitations? Computer simulations offer some limited evidence<sup> </sup>that it will, but further study is warranted to assess its performance<sup> </sup>under various departures from its assumptions. If the method<sup> </sup>proves robust, it will be a very useful tool for policy-makers<sup> </sup>in the midst of an outbreak. Rapid assessment of the reproductive<sup> </sup>number of an emerging infection in the absence of interventions<sup> </sup>is a crucial first step in understanding and controlling the<sup> </sup>disease.<sup> </sup>
Control of a disease in a population requires that the reproductive<sup> </sup>number be brought below 1 and kept there. By assessing the initial<sup> </sup>reproductive number (before the implementation of control measures),<sup> </sup>health officials can estimate the magnitude of the control measures<sup> </sup>that will be necessary. As the infection spreads in a particular<sup> </sup>population and as control measures are instituted, real-time<sup> </sup>tracking is needed to establish the impact of control. The success<sup> </sup>of a control program for a disease like SARS, in which isolation<sup> </sup>of symptomatic patients and quarantine of contacts were the<sup> </sup>key control measures, can be measured in part by "process" indicators,<sup> </sup>such as the time from the onset of symptoms in a case to the<sup> </sup>isolation of that case to prevent transmission, or the fraction<sup> </sup>of incident cases that were identified by contact tracing prior<sup> </sup>to symptom onset. However, real-time measurements of disease<sup> </sup>transmission, using methods like the one developed by Wallinga<sup> </sup>and Teunis, will provide "bottom-line" evidence of whether an<sup> </sup>epidemic is being brought under control. During the 2003 SARS<sup> </sup>outbreak, health officials used a conservative definition?no<sup> </sup>new cases in a time span exceeding twice the longest known incubation<sup> </sup>period for the infection?to declare an epidemic fully<sup> </sup>controlled in a particular jurisdiction, but health officials<sup> </sup>responsible for daily control efforts need a more immediate<sup> </sup>and quantitative measure of the effects of control measures<sup> </sup>as they work toward the goal of eliminating the local epidemic.<sup> </sup>Wallinga and Teunis? method of tracking the instantaneous<sup> </sup>reproductive number provides just such a measure.<sup> </sup>
More broadly, new tools are needed to facilitate data entry,<sup> </sup>management, visualization, analysis, and forecasting in the<sup> </sup>early days of an outbreak. For example, epidemiologists attempting<sup> </sup>to track a natural outbreak of a disease like SARS or pandemic<sup> </sup>influenza or the deliberate release of a biologic agent would<sup> </sup>benefit from the ability to manipulate a rapidly changing database<sup> </sup>with ease, to map spatial and temporal patterns in disease incidence<sup> </sup>according to the home, school, hospital, or workplace of cases,<sup> </sup>and to perform key analyses in ways that have been thought through<sup> </sup>and validated in advance. As data become available during the<sup> </sup>course of an epidemic, public health officials should have at<sup> </sup>their disposal tools to allow the integration of these data<sup> </sup>into real-time predictions of the relative costs and benefits<sup> </sup>of potential control strategies. Many such tools were developed<sup> </sup>in real time during the 2001 epizootic outbreak of foot-and-mouth<sup> </sup>disease in the United Kingdom (7), and since then, refined methods<sup> </sup>for "predictive" vaccination strategies have been proposed (8).<sup> </sup>It would be encouraging to see similar effort being put toward<sup> </sup>planning for human disease outbreaks.<sup> </sup>
Spurred by the perceived threat of biological terrorism, current<sup> </sup>epidemiologic efforts to prepare for outbreaks have taken two<sup> </sup>major forms. The first is the development of "syndromic surveillance"<sup> </sup>systems designed to detect the first anomalous cases and alert<sup> </sup>health officials that an outbreak is under way (9). While they<sup> </sup>are well suited to this purpose, such systems are not designed<sup> </sup>to provide much additional information once the outbreak has<sup> </sup>been identified. Other efforts have concentrated on modeling<sup> </sup>particular attack scenarios with different pathogens, particularly<sup> </sup>smallpox (10, 11) and anthrax (12, 13). These models provide<sup> </sup>valuable a priori guidance about the range of possible responses<sup> </sup>to given scenarios, but they require, of necessity, untestable<sup> </sup>assumptions about the size and nature of the outbreak; moreover,<sup> </sup>to some degree, each of these models gives results whose application<sup> </sup>is limited to the pathogen under consideration or pathogens<sup> </sup>that closely resemble it. As with syndromic surveillance, the<sup> </sup>usefulness of such models is greatest prior to or at the moment<sup> </sup>of an attack, but unless the models are designed to incorporate<sup> </sup>up-to-the-minute data on the state of the outbreak, they will<sup> </sup>provide limited real-time assistance once an outbreak is under<sup> </sup>way.<sup> </sup>
Given the indisputable creativity of Nature and the potential<sup> </sup>creativity of biologically sophisticated evildoers, we cannot<sup> </sup>expect to have an appropriate a priori model for every outbreak.<sup> </sup>Therefore, development of tools for understanding and responding<sup> </sup>to a novel outbreak as it unfolds is a pressing task, and one<sup> </sup>that differs from those that have received the most epidemiologic<sup> </sup>attention thus far. Transmission models, as well as the spatial-temporal<sup> </sup>analysis tools used in syndromic surveillance, may be readily<sup> </sup>adapted to meet the need for analysis of and response to an<sup> </sup>outbreak in progress, but the adaptation requires additional<sup> </sup>work. The technique described by Wallinga and Teunis would be<sup> </sup>a valuable component of a suite of tools that should be made<sup> </sup>available to public health officials before the next important<sup> </sup>outbreak occurs.<sup> </sup>
<sup> </sup>
<!-- null -->
<table bgcolor="#e1e1e1" cellpadding="0" cellspacing="0" width="100%"> <tbody><tr><td align="left" bgcolor="#ffffff" valign="middle" width="5%">
</td> <th align="left" valign="middle" width="95%">[SIZE=+2] NOTES [/SIZE]</th></tr></tbody></table>
<!-- null --> Correspondence to Dr. Marc Lipsitch, Department of Epidemiology,<sup> </sup>Harvard School of Public Health, 677 Huntington Avenue, Boston,<sup> </sup>MA 02115 (e-mail: mlipsitc@hsph.harvard.edu<script type="text/javascript"><!-- var u = "mlipsitc", d = "hsph.harvard.edu"; document.getElementById("em0").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script>).<sup> </sup>
<!-- null -->
<table bgcolor="#e1e1e1" cellpadding="0" cellspacing="0" width="100%"> <tbody><tr><td align="left" bgcolor="#ffffff" valign="middle" width="5%">
</td> <th align="left" valign="middle" width="95%">[SIZE=+2] REFERENCES [/SIZE]</th></tr></tbody></table> <table align="right" border="1" cellpadding="5"><tbody><tr><th align="left">[SIZE=-1]
TOP
REFERENCES
[/SIZE]</th></tr></tbody></table>
ORIGINAL CONTRIBUTIONS
Invited Commentary: Real-Time Tracking of Control Measures for Emerging Infections
<nobr>Marc Lipsitch<sup>1</sup><sup> </sup></nobr> and <nobr>Ca
rl T. Bergstrom<sup>2</sup></nobr> [SIZE=-1] <sup>1</sup> Department of Epidemiology, Harvard School of Public Health, Boston, MA.
<sup>2</sup> Department of Biology, University of Washington, Seattle, WA. [/SIZE]
[SIZE=-1]Received for publication May 17, 2004; accepted for publication June 3, 2004.[/SIZE]
<!-- null --> Health officials faced a daunting task with the emergence of<sup> </sup>severe acute respiratory syndrome (SARS) last year: forecasting<sup> </sup>the trajectory of an emerging infectious disease and implementing<sup> </sup>effective control measures, even as the etiologic agent was<sup> </sup>still being identified. Investigators initially had little to<sup> </sup>go on beyond crude epidemiologic data such as the timing of<sup> </sup>new cases (the epidemic curve). With such limited data, it was<sup> </sup>difficult to disentangle two fundamental epidemiologic quantities:<sup> </sup>the time from one transmission of the infection to the next,<sup> </sup>known as the serial interval or generation time, and the average<sup> </sup>number of secondary cases resulting from each infection, known<sup> </sup>as the reproductive number.<sup> </sup>
A simple example illustrates the problem. Compare two idealized<sup> </sup>diseases, A and B. Disease A has a short generation time of<sup> </sup>4 days but has relatively low transmissibility, such that each<sup> </sup>primary infection generates two secondary infections. Disease<sup> </sup>B has a longer generation time of 8 days but is more transmissible,<sup> </sup>such that each primary infection generates four secondary infections.<sup> </sup>The initial epidemic curves for these two infections will be<sup> </sup>nearly superimposable, with approximately a doubling of new<sup> </sup>cases every 4 days. (These calculations are approximate. In<sup> </sup>fact, the generation time for any given transmission will be<sup> </sup>a random variable, with some distribution. This distribution<sup> </sup>will affect the precise doubling time of the epidemic and will<sup> </sup>also affect the shape of the epidemic curve in the period before<sup> </sup>the epidemic enters an exponential growth phase (1?3).)<sup> </sup>Thus, investigators cannot separate generation time from reproductive<sup> </sup>number on the basis of the epidemic curves alone. As a result,<sup> </sup>they are limited in their ability to predict the efficacy of<sup> </sup>potential interventions. Despite nearly identical epidemic curves,<sup> </sup>an outbreak of disease A can stemmed by an intervention that<sup> </sup>reduces transmission threefold, while disease B will continue<sup> </sup>to spread even with such control measures in place.<sup> </sup>
In the current issue of the Journal, Wallinga and Teunis (4)<sup> </sup>present a statistical escape from this analytical Catch-22.<sup> </sup>Their approach is this: Once epidemiologists have traced the<sup> </sup>chains of transmission in a single isolated outbreak, they can<sup> </sup>use the transmission network to infer the distribution of generation<sup> </sup>times for that disease. This distribution, which results from<sup> </sup>the biology of host-pathogen interaction, should be relatively<sup> </sup>constant in comparison with transmission rates, which will vary<sup> </sup>from location to location and over the course of an epidemic<sup> </sup>as the pool of susceptible persons declines and as control measures<sup> </sup>are implemented. Therefore, investigators can use this generation<sup> </sup>time distribution as a grounding point from which to infer the<sup> </sup>reproductive number, R, from epidemic curves observed in other<sup> </sup>settings where extensive contact tracing may not have been achieved.<sup> </sup>Most importantly, Wallinga and Teunis describe an elegant method<sup> </sup>for following the instantaneous reproductive number as it evolves<sup> </sup>over time in a single epidemic. They provide a means of transforming<sup> </sup>the time series of cases, along with a "known" distribution<sup> </sup>for the generation time, into a time series of estimated values<sup> </sup>for the instantaneous reproductive number on each day.<sup> </sup>
This method allows nearly real-time tracking of the effect<sup> </sup>of control measures and other changes in an epidemic on the<sup> </sup>level of transmission ongoing in the population. Estimates are<sup> </sup>not precisely real-time, because accurate estimates of the instantaneous<sup> </sup>reproductive number on a given date cannot be made until some<sup> </sup>time after that date. Specifically, one can only estimate the<sup> </sup>number of persons a given case has infected when a sufficient<sup> </sup>amount of time has passed that all patients with secondary cases<sup> </sup>generated by that case (and by other, surrounding cases) have<sup> </sup>become infected, become symptomatic, and had their infections<sup> </sup>reported. While this lag period (slightly more than the generation<sup> </sup>time, plus the incubation period, plus the reporting delay)<sup> </sup>could be decades long for diseases with extended latency periods<sup> </sup>such as human immunodeficiency virus disease, in the case of<sup> </sup>SARS the lag period is a matter of a few weeks, and the information<sup> </sup>provided is as fresh as one could obtain, given the available<sup> </sup>data.<sup> </sup>
Wallinga and Teunis?s elegantly simple approach is related<sup> </sup>to more complex applications of back-calculation that have been<sup> </sup>used to derive incidence of infection from data on disease prevalence<sup> </sup>or incidence in human immunodeficiency virus disease (5) and<sup> </sup>to derive annual average reproductive numbers from case data<sup> </sup>in the United Kingdom epidemic of bovine spongiform encephalopathy<sup> </sup>(6). The present work is distinguished by its real-time applicability<sup> </sup>to a rapidly transmitted disease and its requirements for only<sup> </sup>the serial interval distribution and the epidemic curve as inputs.<sup> </sup>
In their report (4), Wallinga and Teunis demonstrate the power<sup> </sup>of this analytical approach by improving our understanding of<sup> </sup>the 2003 SARS outbreaks in Hong Kong, Vietnam, Singapore, and<sup> </sup>Canada. The authors find that despite the very different epidemic<sup> </sup>curves observed in each location, pre-intervention reproductive<sup> </sup>numbers appear to have been similar. Furthermore, they infer<sup> </sup>that control interventions appear to have reduced transmission<sup> </sup>rates approximately fourfold in each location?enough to<sup> </sup>stop the epidemics, but only barely.<sup> </sup>
Like any model, this one has some limitations, which the authors<sup> </sup>note. First, the method makes the simplifying assumption of<sup> </sup>independence of transmission events?that the assignment<sup> </sup>of a source to any case A is independent of the assignment of<sup> </sup>the source to each other case B. This is, at best, an approximation.<sup> </sup>For example, if different persons vary in their degree of infectiousness<sup> </sup>(e.g., because of differences in viral shedding) or in their<sup> </sup>duration of infectiousness, the numbers of secondary infections<sup> </sup>per individual will be overdispersed (even within the same short<sup> </sup>time period). Put another way, if we know that case i was still<sup> </sup>infectious at a time when case j became infected, we know that<sup> </sup>case i is a likely candidate for having infected other secondary<sup> </sup>cases around the same time. Second, the method assumes that<sup> </sup>interventions do not affect the generation time of the pathogen.<sup> </sup>In reality, when interventions involve improved monitoring followed<sup> </sup>by either isolation or effective treatment, most transmissions<sup> </sup>will occur early, before detection. As a result, the mean generation<sup> </sup>time will be reduced, and the algorithm presented here could<sup> </sup>lead to an overestimate of the instantaneous transmission rate<sup> </sup>for the period subsequent to intervention.<sup> </sup>
So will Wallinga and Teunis?s approach work despite these<sup> </sup>limitations? Computer simulations offer some limited evidence<sup> </sup>that it will, but further study is warranted to assess its performance<sup> </sup>under various departures from its assumptions. If the method<sup> </sup>proves robust, it will be a very useful tool for policy-makers<sup> </sup>in the midst of an outbreak. Rapid assessment of the reproductive<sup> </sup>number of an emerging infection in the absence of interventions<sup> </sup>is a crucial first step in understanding and controlling the<sup> </sup>disease.<sup> </sup>
Control of a disease in a population requires that the reproductive<sup> </sup>number be brought below 1 and kept there. By assessing the initial<sup> </sup>reproductive number (before the implementation of control measures),<sup> </sup>health officials can estimate the magnitude of the control measures<sup> </sup>that will be necessary. As the infection spreads in a particular<sup> </sup>population and as control measures are instituted, real-time<sup> </sup>tracking is needed to establish the impact of control. The success<sup> </sup>of a control program for a disease like SARS, in which isolation<sup> </sup>of symptomatic patients and quarantine of contacts were the<sup> </sup>key control measures, can be measured in part by "process" indicators,<sup> </sup>such as the time from the onset of symptoms in a case to the<sup> </sup>isolation of that case to prevent transmission, or the fraction<sup> </sup>of incident cases that were identified by contact tracing prior<sup> </sup>to symptom onset. However, real-time measurements of disease<sup> </sup>transmission, using methods like the one developed by Wallinga<sup> </sup>and Teunis, will provide "bottom-line" evidence of whether an<sup> </sup>epidemic is being brought under control. During the 2003 SARS<sup> </sup>outbreak, health officials used a conservative definition?no<sup> </sup>new cases in a time span exceeding twice the longest known incubation<sup> </sup>period for the infection?to declare an epidemic fully<sup> </sup>controlled in a particular jurisdiction, but health officials<sup> </sup>responsible for daily control efforts need a more immediate<sup> </sup>and quantitative measure of the effects of control measures<sup> </sup>as they work toward the goal of eliminating the local epidemic.<sup> </sup>Wallinga and Teunis? method of tracking the instantaneous<sup> </sup>reproductive number provides just such a measure.<sup> </sup>
More broadly, new tools are needed to facilitate data entry,<sup> </sup>management, visualization, analysis, and forecasting in the<sup> </sup>early days of an outbreak. For example, epidemiologists attempting<sup> </sup>to track a natural outbreak of a disease like SARS or pandemic<sup> </sup>influenza or the deliberate release of a biologic agent would<sup> </sup>benefit from the ability to manipulate a rapidly changing database<sup> </sup>with ease, to map spatial and temporal patterns in disease incidence<sup> </sup>according to the home, school, hospital, or workplace of cases,<sup> </sup>and to perform key analyses in ways that have been thought through<sup> </sup>and validated in advance. As data become available during the<sup> </sup>course of an epidemic, public health officials should have at<sup> </sup>their disposal tools to allow the integration of these data<sup> </sup>into real-time predictions of the relative costs and benefits<sup> </sup>of potential control strategies. Many such tools were developed<sup> </sup>in real time during the 2001 epizootic outbreak of foot-and-mouth<sup> </sup>disease in the United Kingdom (7), and since then, refined methods<sup> </sup>for "predictive" vaccination strategies have been proposed (8).<sup> </sup>It would be encouraging to see similar effort being put toward<sup> </sup>planning for human disease outbreaks.<sup> </sup>
Spurred by the perceived threat of biological terrorism, current<sup> </sup>epidemiologic efforts to prepare for outbreaks have taken two<sup> </sup>major forms. The first is the development of "syndromic surveillance"<sup> </sup>systems designed to detect the first anomalous cases and alert<sup> </sup>health officials that an outbreak is under way (9). While they<sup> </sup>are well suited to this purpose, such systems are not designed<sup> </sup>to provide much additional information once the outbreak has<sup> </sup>been identified. Other efforts have concentrated on modeling<sup> </sup>particular attack scenarios with different pathogens, particularly<sup> </sup>smallpox (10, 11) and anthrax (12, 13). These models provide<sup> </sup>valuable a priori guidance about the range of possible responses<sup> </sup>to given scenarios, but they require, of necessity, untestable<sup> </sup>assumptions about the size and nature of the outbreak; moreover,<sup> </sup>to some degree, each of these models gives results whose application<sup> </sup>is limited to the pathogen under consideration or pathogens<sup> </sup>that closely resemble it. As with syndromic surveillance, the<sup> </sup>usefulness of such models is greatest prior to or at the moment<sup> </sup>of an attack, but unless the models are designed to incorporate<sup> </sup>up-to-the-minute data on the state of the outbreak, they will<sup> </sup>provide limited real-time assistance once an outbreak is under<sup> </sup>way.<sup> </sup>
Given the indisputable creativity of Nature and the potential<sup> </sup>creativity of biologically sophisticated evildoers, we cannot<sup> </sup>expect to have an appropriate a priori model for every outbreak.<sup> </sup>Therefore, development of tools for understanding and responding<sup> </sup>to a novel outbreak as it unfolds is a pressing task, and one<sup> </sup>that differs from those that have received the most epidemiologic<sup> </sup>attention thus far. Transmission models, as well as the spatial-temporal<sup> </sup>analysis tools used in syndromic surveillance, may be readily<sup> </sup>adapted to meet the need for analysis of and response to an<sup> </sup>outbreak in progress, but the adaptation requires additional<sup> </sup>work. The technique described by Wallinga and Teunis would be<sup> </sup>a valuable component of a suite of tools that should be made<sup> </sup>available to public health officials before the next important<sup> </sup>outbreak occurs.<sup> </sup>
<sup> </sup>
<!-- null -->
<table bgcolor="#e1e1e1" cellpadding="0" cellspacing="0" width="100%"> <tbody><tr><td align="left" bgcolor="#ffffff" valign="middle" width="5%">
<!-- null --> Correspondence to Dr. Marc Lipsitch, Department of Epidemiology,<sup> </sup>Harvard School of Public Health, 677 Huntington Avenue, Boston,<sup> </sup>MA 02115 (e-mail: mlipsitc@hsph.harvard.edu<script type="text/javascript"><!-- var u = "mlipsitc", d = "hsph.harvard.edu"; document.getElementById("em0").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script>).<sup> </sup>
<!-- null -->
<table bgcolor="#e1e1e1" cellpadding="0" cellspacing="0" width="100%"> <tbody><tr><td align="left" bgcolor="#ffffff" valign="middle" width="5%">
[/SIZE]</th></tr></tbody></table>
- <!-- null -->
- Lipsitch M, Cohen T, Cooper B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003;300:1966?70.<!-- HIGHWIRE ID="160:6:517:1" --><nobr>[Abstract/Free Full Text]</nobr><!-- /HIGHWIRE --><!-- null -->
- Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford, United Kingdom: Oxford University Press, 1991.<!-- HIGHWIRE ID="160:6:517:2" --><!-- /HIGHWIRE --><!-- null -->
- Diekmann O, Heesterbeek JA. Mathematical epidemiology of infectious diseases: model building, analysis and interpretation. New York, NY: John Wiley and Sons, 2001.<!-- HIGHWIRE ID="160:6:517:3" --><!-- /HIGHWIRE --><!-- null -->
- Wallinga J, Teunis P. Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. Am J Epidemiol 2004;160:509?16.<!-- HIGHWIRE ID="160:6:517:4" --><nobr>[Abstract/Free Full Text]</nobr><!-- /HIGHWIRE --><!-- null -->
- Becker NG, Marschner IC. Advances in medical statistics arising from the AIDS epidemic. Stat Methods Med Res 2001;10:117?40.<!-- HIGHWIRE ID="160:6:517:5" -->[CrossRef][ISI][Medline]<!-- /HIGHWIRE --><!-- null -->
- Ferguson NM, Donnelly CA, Woolhouse ME, et al. Estimation of the basic reproduction number of BSE: the intensity of transmission in British cattle. Proc R Soc Lond B Biol Sci 1999;266:23?32.<!-- HIGHWIRE ID="160:6:517:6" -->[CrossRef][ISI][Medline]<!-- /HIGHWIRE --><!-- null -->
- Ferguson NM, Donnelly CA, Anderson RM. The foot-and-mouth epidemic in Great Britain: pattern of spread and impact of interventions. Science 2001;292:1155?60.<!-- HIGHWIRE ID="160:6:517:7" --><nobr>[Abstract/Free Full Text]</nobr><!-- /HIGHWIRE --><!-- null -->
- Keeling MJ, Woolhouse ME, May RM, et al. Modelling vaccination strategies against foot-and-mouth disease. Nature 2003;421:136?42.<!-- HIGHWIRE ID="160:6:517:8" -->[CrossRef][ISI][Medline]<!-- /HIGHWIRE --><!-- null -->
- Mandl KD, Overhage JM, Wagner MM, et al. Implementing syndromic surveillance: a practical guide informed by the early experience. J Am Med Inform Assoc 2004;11:141?50.<!-- HIGHWIRE ID="160:6:517:9" --><nobr>[Abstract/Free Full Text]</nobr><!-- /HIGHWIRE --><!-- null -->
- Halloran ME, Longini IM Jr, Nizam A, et al. Containing bioterrorist smallpox. Science 2002;298:1428?32.<!-- HIGHWIRE ID="160:6:517:10" --><nobr>[Abstract/Free Full Text]</nobr><!-- /HIGHWIRE --><!-- null -->
- Kaplan EH, Craft DL, Wein LM. Emergency response to a smallpox attack: the case for mass vaccination. Proc Natl Acad Sci U S A 2002;99:10935?40.<!-- HIGHWIRE ID="160:6:517:11" --><nobr>[Abstract/Free Full Text]</nobr><!-- /HIGHWIRE --><!-- null -->
- Brookmeyer R, Johnson E, Bollinger R. Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak. Proc Natl Acad Sci U S A 2003;100:10129?32.<!-- HIGHWIRE ID="160:6:517:12" --><nobr>[Abstract/Free Full Text]</nobr><!-- /HIGHWIRE --><!-- null -->
- Webb GF, Blaser MJ. Mailborne transmission of anthrax: modeling and implications. Proc Natl Acad Sci U S A 2002;99:7027?32.<!-- HIGHWIRE ID="160:6:517:13" --><nobr>[Abstract/Free Full Text]</nobr><!-- /HIGHWIRE -->